These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8491007)

  • 21. Long-term implications of reocclusion on left ventricular size and function after successful thrombolysis for first anterior myocardial infarction.
    Nijland F; Kamp O; Verheugt FW; Veen G; Visser CA
    Circulation; 1997 Jan; 95(1):111-7. PubMed ID: 8994425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
    Haskel EJ; Prager NA; Sobel BE; Abendschein DR
    Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).
    Cohen M; Adams PC; Hawkins L; Bach M; Fuster V
    Am J Cardiol; 1990 Dec; 66(19):1287-92. PubMed ID: 2244556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.
    Jun L; Arnout J; Vanhove P; Dol F; Lormeau JC; Herbert JM; Collen D; Van de Werf F
    Coron Artery Dis; 1995 Mar; 6(3):257-63. PubMed ID: 7788040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
    Langer A; Fisher M; Califf RM; Goodman S; O'Connor CM; Harrington RA; Fuster V
    Can J Cardiol; 1999 Oct; 15(10):1095-102. PubMed ID: 10523476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clopidogrel is more effective than aspirin as adjuvant treatment to prevent reocclusion after thrombolysis.
    Yao SK; Ober JC; Ferguson JJ; Maffrand JP; Anderson HV; Buja LM; Willerson JT
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H488-93. PubMed ID: 8067400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defibrotide versus heparin in the prevention of coronary reocclusion after thrombolysis in acute myocardial infarction.
    Tubaro M; Mattioli G; Matta F; Cappello C; Natale E; Ricci R; Gerardi P; Milazzotto F
    Cardiovasc Drugs Ther; 1993 Nov; 7(5):809-16. PubMed ID: 8110625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Adams PC; Parry G; Xiong J; Chamberlain D; Wieczorek I; Fox KA; Chesebro JH; Strain J; Keller C
    Circulation; 1994 Jan; 89(1):81-8. PubMed ID: 8281698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incidence of residual thrombi following successful thrombolytic therapy in acute myocardial infarct and their significance for the rate of early re-occlusion. A report of a multicenter dose-finding study for thrombolytic therapy with urokinase preactivated natural prourokinase (TCL 598)].
    Gulba DC; Bode C; Topp J; Höpp HW; Westhoff-Bleck M; Rafflenbeul W; Lichtlen PR
    Z Kardiol; 1990 Apr; 79(4):279-85. PubMed ID: 2113330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction.
    Malcolm AD; Keltai M; Walsh MJ
    Eur Heart J; 1996 Oct; 17(10):1522-31. PubMed ID: 8909909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
    Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
    Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
    White HD; Aylward PE; Frey MJ; Adgey AA; Nair R; Hillis WS; Shalev Y; Brown MA; French JK; Collins R; Maraganore J; Adelman B
    Circulation; 1997 Oct; 96(7):2155-61. PubMed ID: 9337184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary stenting (Cordis) without anticoagulation.
    Park SW; Park SJ; Hong MK; Kim JJ; Cho SY; Jang YS; Kim KB; Kim KS; Oh DJ; Oh BH; Kang JC
    Am J Cardiol; 1997 Apr; 79(7):901-4. PubMed ID: 9104903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial.
    Schaer GL; Spaccavento LJ; Browne KF; Krueger KA; Krichbaum D; Phelan JM; Fletcher WO; Grines CL; Edwards S; Jolly MK; Gibbons RJ
    Circulation; 1996 Aug; 94(3):298-307. PubMed ID: 8759069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
    Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjunctive therapy in thrombolysis for acute myocardial infarction.
    Bleich SD; Rolston WA; Tilton GD; Mailander L
    Z Kardiol; 1993; 82 Suppl 2():179-82. PubMed ID: 8328199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
    Circulation; 1994 Apr; 89(4):1545-56. PubMed ID: 8149520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term infarct vessel patency with aspirin and dipyridamole started 24 to 36 hours after intravenous streptokinase.
    Hays LJ; Beller GA; Moore CA; Burwell LR; Craddock GB; Gascho JA; Smucker ML; Tedesco C; Nygaard TW
    Am Heart J; 1988 Apr; 115(4):717-21. PubMed ID: 3354400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.